1-4 of 4
Peng Yuan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients: A Phase I Clinical Trial

Qiao Li, Xiuwen Guan, Shanshan Chen, Zongbi Yi, Bo Lan, Puyuan Xing, Ying Fan, Jiayu Wang, Yang Luo, Peng Yuan, Ruigang Cai, Pin Zhang, Qing Li, Dafang Zhong, Yifan Zhang, Jianjun Zou, Xiaoyu Zhu, Fei Ma, Binghe Xu
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (17): 5212–5220.
https://doi.org/10.1158/1078-0432.CCR-18-4173
Published: 03 September 2019
View article titled, Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients: A Phase I Clinical Trial
Open the PDF for Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients: A Phase I Clinical Trial in another window
Includes: Supplementary data
Journal Articles

Depletion of Tumor-Associated Macrophages Enhances the Effect of Sorafenib in Metastatic Liver Cancer Models by Antimetastatic and Antiangiogenic Effects

Wei Zhang, Xiao-Dong Zhu, Hui-Chuan Sun, Yu-Quan Xiong, Peng-Yuan Zhuang, Hua-Xiang Xu, Ling-Qun Kong, Lu Wang, Wei-Zhong Wu, Zhao-You Tang
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (13): 3420–3430.
https://doi.org/10.1158/1078-0432.CCR-09-2904
Published: 30 June 2010
View article titled, Depletion of Tumor-Associated Macrophages Enhances the Effect of Sorafenib in Metastatic Liver Cancer Models by Antimetastatic and Antiangiogenic Effects
Open the PDF for Depletion of Tumor-Associated Macrophages Enhances the Effect of Sorafenib in Metastatic Liver Cancer Models by Antimetastatic and Antiangiogenic Effects in another window
Includes: Supplementary data
Journal Articles

Human Hepatocellular Carcinoma Tumor–derived Endothelial Cells Manifest Increased Angiogenesis Capability and Drug Resistance Compared with Normal Endothelial Cells

Yu-Quan Xiong, Hui-Chuan Sun, Wei Zhang, Xiao-Dong Zhu, Peng-Yuan Zhuang, Ju-Bo Zhang, Lu Wang, Wei-zhong Wu, Lun-Xiu Qin, Zhao-You Tang
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (15): 4838–4846.
https://doi.org/10.1158/1078-0432.CCR-08-2780
Published: 29 July 2009
View article titled, Human Hepatocellular Carcinoma Tumor–derived Endothelial Cells Manifest Increased Angiogenesis Capability and Drug Resistance Compared with Normal Endothelial Cells
Open the PDF for Human Hepatocellular Carcinoma Tumor–derived Endothelial Cells Manifest Increased Angiogenesis Capability and Drug Resistance Compared with Normal Endothelial Cells in another window
Includes: Supplementary data
Journal Articles

Characterization of Functional Excision Repair Cross-Complementation Group 1 Variants and Their Association with Lung Cancer Risk and Prognosis

Dianke Yu, Xuemei Zhang, Ju Liu, Peng Yuan, Wen Tan, Yongli Guo, Tong Sun, Dan Zhao, Ming Yang, Junniao Liu, Binghe Xu, Dongxin Lin
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (9): 2878–2886.
https://doi.org/10.1158/1078-0432.CCR-07-1612
Published: 01 May 2008
View article titled, Characterization of Functional Excision Repair Cross-Complementation Group 1 Variants and Their Association with Lung Cancer Risk and Prognosis
Open the PDF for Characterization of Functional Excision Repair Cross-Complementation Group 1 Variants and Their Association with Lung Cancer Risk and Prognosis in another window
Includes: Supplementary data